Pacira to acquire VC-backed MyoScience

Pacira Pharmaceuticals Inc has agreed to acquire MyoScience, a medical tech company. Pacira will make an initial payment of $120 million with an additional $100 million contingent upon the fulfillment of certain milestones. MyoScience's backers include Accuitive Medical Ventures, American Equities Overseas, DeNovo Ventures, Nexus Medical Partners, Valiance and Sobera Capital.

6 March 2019•6 mins read
Feature image
LinkedInXEmail
LinkedInXEmail